SCHEMBL19495403

SCHEMBL19495403

CC(Nc1nc(Cl)cc2nccnc12)[C@H]1CN(C(=O)OC(C)(C)C)CCO1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHA2 P29317 4/20 0.39
▸ ERBB2 P04626 1/20 0.39
▸ EPHB4 P54760 1/20 0.39
▸ MALT1 Q9UDY8 1/20 0.38
▸ USP30 Q70CQ3 3/20 0.35
▸ HTT P42858 2/20 0.34
▸ POLB P06746 1/20 0.34
▸ ATM Q13315 1/20 0.34
▸ MAPK1 P28482 3/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33
▸ ADORA2A P29274 1/20 0.33
▸ ADORA2B P29275 1/20 0.33
▸ KEAP1 Q14145 1/20 0.33
▸ NFE2L2 Q16236 1/20 0.33
▸ GPR119 Q8TDV5 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15656277 1.00 EPHA2 (0.39) EPHA2ERBB2EPHB4MALT1USP30
SCHEMBL14242319 1.00 EPHA2 (0.39) EPHA2ERBB2EPHB4MALT1USP30
SCHEMBL15656279 1.00 EPHA2 (0.39) EPHA2ERBB2EPHB4MALT1USP30
SCHEMBL12527149 0.85 EPHA2 (0.44) EPHA2ERBB2EPHB4MALT1
SCHEMBL15656132 0.85 EPHA2 (0.44) EPHA2ERBB2EPHB4MALT1
SCHEMBL15775171 0.85 MALT1 (0.36) EPHA2ERBB2EPHB4MALT1USP30
SCHEMBL15774924 0.85 MALT1 (0.36) EPHA2ERBB2EPHB4MALT1USP30
SCHEMBL12527236 0.85 EPHA2 (0.44) EPHA2ERBB2EPHB4MALT1
SCHEMBL15774886 0.85 MALT1 (0.36) EPHA2ERBB2EPHB4MALT1USP30
SCHEMBL15774925 0.85 MALT1 (0.36) EPHA2ERBB2EPHB4MALT1USP30

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2718293-B1 SUBSTITUTED PYRIDOPYRAZINES AS NOVEL SYK INHIBITORS HUTCHISON MEDIPHARMA LTD (CN) 2017-10-25 — — EP disclosed
Send feedback